Impact of Concurrent Medication Use on Pancreatic Cancer Survival—SEER-Medicare Analysis

Abstract

In this study, use of β-blockers, heparin, insulin, and warfarin were associated with improved survival in patients with pancreatic cancer. Additional studies are needed to validate these findings in the clinical setting.